The Treatment Responses in Cases of Radiation Therapy to Portal Vein Thrombosis in Advanced Hepatocellular Carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 73, Issue 4, 2009, Pages 1155-1163

  Huang, Yu Jie ^a   Hsu, Hsuan Chih ^a   Wang, Chang Yu ^a   Wang, Chong Jong ^a   Chen, Hui Chun ^a   Huang, Eng Yen ^a   Fang, Fu Min ^a   Lu, Sheng Nan ^b  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Hepatocellular carcinoma; Portal vein; Prognosis; Radiotherapy; Thrombosis

Indexed keywords

DOSIMETRY; RADIOTHERAPY;

CLINICAL FEATURES; COMPLETE RESPONSE; FETOPROTEIN; HAZARD RATIOS; HEPATOCELLULAR CARCINOMA; INDEPENDENT VARIABLES; MEDIAN SURVIVAL TIME; PARTIAL RESPONSE; PERFORMANCE STATUS; PORTAL VEIN; PORTAL VEIN THROMBOSIS; PROGNOSIS; RADIATION DOSE; RADIATION THERAPIES; RISK FACTORS; STATISTICALLY SIGNIFICANT DIFFERENCES; SURVIVAL TIME; THROMBOSIS; TREATMENT RESPONSE;

RADIATION;

ALBUMIN; ALPHA FETOPROTEIN; HEPATITIS B SURFACE ANTIGEN;

ADULT; ADVANCED CANCER; ALBUMIN BLOOD LEVEL; ARTICLE; ASCITES TUMOR; CANCER LOCALIZATION; CANCER SURVIVAL; CLINICAL FEATURE; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT SELECTION; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL TIME; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR VOLUME;

ANALYSIS OF VARIANCE; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PORTAL VEIN; REGRESSION ANALYSIS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; VENOUS THROMBOSIS;

EID: 61349184364     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.06.1486     Document Type: Article

References (52)

1. Cancer of the Liver Italian Program (CLIP) investigators (Investigators TCotLIP). A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients. Hepatology 28 (1998) 751-755
2. Fong Y., Sun R.L., Jarnagin W., et al. An analysis of 412 cases of hepatocellular carcinoma at a western center. Ann Surg 229 (1999) 790-799 discussion 799-800
3. Pirisi M., Avellini C., Fabris C., et al. Portal vein thrombosis in hepatocellular carcinoma: Age and sex distribution in an autopsy study. J Cancer Res Clin Oncol 124 (1998) 397-400
4. Stuart K.E., Anand A.J., and Jenkins R.L. Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival. Cancer 77 (1996) 2217-2222
5. Ando E., Yamashita F., Tanaka M., et al. A novel chemotherapy for advanced hepatocellular carcinoma with tumor thrombosis of the main trunk of the portal vein. Cancer 79 (1997) 1890-1896
6. Llovet J.M., Bustamante J., Castells A., et al. Natural history of untreated nonsurgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trials. Hepatology 29 (1999) 62-67
7. Bruix J., and Sherman M. Management of hepatocellular carcinoma. Hepatology 42 (2005) 1208-1236
8. Ando E., Tanaka M., Yamashita F., et al. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: Analysis of 48 cases. Cancer 95 (2002) 588-595
9. Minagawa M., Makuuchi M., Takayama T., et al. Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus. Ann Surg 233 (2001) 379-384
10. Yen F.S., Wu J.C., Kuo B.I., et al. Transcatheter arterial embolization for hepatocellular carcinoma with portal vein thrombosis. J Gastroenterol Hepatol 10 (1995) 237-240
11. Cheng S.H., Lin Y.M., Chuang V.P., et al. A pilot study of three-dimensional conformal radiotherapy in unresectable hepatocellular carcinoma. J Gastroenterol Hepatol 14 (1999) 1025-1033
12. Ishikura S., Ogino T., Furuse J., et al. Radiotherapy after transcatheter arterial chemoembolization for patients with hepatocellular carcinoma and portal vein tumor thrombus. Am J Clin Oncol 25 (2002) 189-193
13. Nakagawa K., Yamashita H., Shiraishi K., et al. Radiation therapy for portal venous invasion by hepatocellular carcinoma. World J Gastroenterol 11 (2005) 7237-7241
14. Zeng Z.C., Fan J., Tang Z.Y., et al. A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombus. Int J Radiat Oncol Biol Phys 61 (2005) 432-443
15. Oken M.M., Creech R.H., Tormey D.C., et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5 (1982) 649-655
16. Austin-Seymour M.M., Chen G.T., Castro J.R., et al. Dose volume histogram analysis of liver radiation tolerance. Int J Radiat Oncol Biol Phys 12 (1986) 31-35
17. Lawrence T.S., Robertson J.M., Anscher M.S., et al. Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys 31 (1995) 1237-1248
18. Yamaoka Y., Kumada K., Ino K., et al. Liver resection for hepatocellular carcinoma (HCC) with direct removal of tumor thrombi in the main portal vein. World J Surg 16 (1992) 1172-1176 discussion 1177
19. Lau W.Y., Ho S.K., Yu S.C., et al. Salvage surgery following downstaging of unresectable hepatocellular carcinoma. Ann Surg 240 (2004) 299-305
20. Ikai I., Hatano E., Hasegawa S., et al. Prognostic index for patients with hepatocellular carcinoma combined with tumor thrombosis in the major portal vein. J Am Coll Surg 202 (2006) 431-438
21. Le Treut Y.P., Hardwigsen J., Ananian P., et al. Resection of hepatocellular carcinoma with tumor thrombus in the major vasculature. A European case-control series. J Gastrointest Surg 10 (2006) 855-862
22. Minagawa M., and Makuuchi M. Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus. World J Gastroenterol 12 (2006) 7561-7567
23. Yamada R., Sato M., Kawabata M., et al. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 148 (1983) 397-401
24. Pelletier G., Roche A., Ink O., et al. A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J Hepatol 11 (1990) 181-184
25. Madden M.V., Krige J.E., Bailey S., et al. Randomised trial of targeted chemotherapy with lipiodol and 5-epidoxorubicin compared with symptomatic treatment for hepatoma. Gut 34 (1993) 1598-1600
26. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 332 (1995) 1256-1261
27. Bruix J., Llovet J.M., Castells A., et al. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: Results of a randomized, controlled trial in a single institution. Hepatology 27 (1998) 1578-1583
28. Pelletier G., Ducreux M., Gay F., et al. Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: A multicenter randomized trial. Groupe CHC. J Hepatol 29 (1998) 129-134
29. Lansing A.M., Davis W.M., and Brizel H.E. Radiation hepatitis. Arch Surg 96 (1968) 876-882
30. Wharton J.T., Delclos L., Gallager S., et al. Radiation hepatitis induced by abdominal irradiation with the cobalt 60 moving strip technique. Am J Roentgenol Radium Ther Nucl Med 117 (1973) 73-80
31. Kim T.H., Panahon A.M., Friedman M., et al. Acute transient radiation hepatitis following whole abdominal irradiation. Clin Radiol 27 (1976) 449-454
32. Lawrence T.S., Ten Haken R.K., Kessler M.L., et al. The use of 3-D dose volume analysis to predict radiation hepatitis. Int J Radiat Oncol Biol Phys 23 (1992) 781-788
33. Tazawa J., Maeda M., Sakai Y., et al. Radiation therapy in combination with transcatheter arterial chemoembolization for hepatocellular carcinoma with extensive portal vein involvement. J Gastroenterol Hepatol 16 (2001) 660-665
34. Yamada K., Soejima T., Sugimoto K., et al. Pilot study of local radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma. Jpn J Clin Oncol 31 (2001) 147-152
35. Kim D.Y., Park W., Lim D.H., et al. Three-dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma. Cancer 103 (2005) 2419-2426
36. Toya R., Murakami R., Baba Y., et al. Conformal radiation therapy for portal vein tumor thrombosis of hepatocellular carcinoma. Radiother Oncol 84 (2007) 266-271
37. Villa E., Moles A., Ferretti I., et al. Natural history of inoperable hepatocellular carcinoma: Estrogen receptors' status in the tumor is the strongest prognostic factor for survival. Hepatology 32 (2000) 233-238
38. Okuda K., Musha H., Yoshida T., et al. Demonstration of growing casts of hepatocellular carcinoma in the portal vein by celiac angiography: The thread and streaks sign. Radiology 117 (1975) 303-309
39. Miller A.B., Hoogstraten B., Staquet M., et al. Reporting results of cancer treatment. Cancer 47 (1981) 207-214
40. Lin C.S., Jen Y.M., Chiu S.Y., et al. Treatment of portal vein tumor thrombosis of hepatoma patients with either stereotactic radiotherapy or three-dimensional conformal radiotherapy. Jpn J Clin Oncol 36 (2006) 212-217
41. Therasse P., Arbuck S.G., Eisenhauer E.A., et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92 (2000) 205-216
42. Harmanci O., and Bayraktar Y. Portal hypertension due to portal venous thrombosis: Etiology, clinical outcomes. World J Gastroenterol 13 (2007) 2535-2540
43. Ohnishi K., Okuda K., Ohtsuki T., et al. Formation of hilar collaterals or cavernous transformation after portal vein obstruction by hepatocellular carcinoma. Observations in ten patients. Gastroenterology 87 (1984) 1150-1153
44. De Gaetano A.M., Lafortune M., Patriquin H., et al. Cavernous transformation of the portal vein: Patterns of intrahepatic and splanchnic collateral circulation detected with Doppler sonography. AJR Am J Roentgenol 165 (1995) 1151-1155
45. Huang Y.H., Chen C.H., Chang T.T., et al. Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery. J Gastroenterol Hepatol 20 (2005) 765-771
46. Marrero J.A., Fontana R.J., Barrat A., et al. Prognosis of hepatocellular carcinoma: Comparison of 7 staging systems in an American cohort. Hepatology 41 (2005) 707-716
47. Toyoda H., Kumada T., Kiriyama S., et al. Comparison of the usefulness of three staging systems for hepatocellular carcinoma (CLIP, BCLC, and JIS) in Japan. Am J Gastroenterol 100 (2005) 1764-1771
48. Nomura F., Ohnishi K., and Tanabe Y. Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patients. Cancer 64 (1989) 1700-1707
49. Tangkijvanich P., Anukulkarnkusol N., Suwangool P., et al. Clinical characteristics and prognosis of hepatocellular carcinoma: Analysis based on serum alpha-fetoprotein levels. J Clin Gastroenterol 31 (2000) 302-308
50. DeVita V.T., Hellman S., and Rosenberg S.A. Cancer: Principles & practice of oncology. 7th ed. (2004), Lippincott Williams & Wilkins, Philadelphia
51. Chou C.H., Chen P.J., Lee P.H., et al. Radiation-induced hepatitis B virus reactivation in liver mediated by the bystander effect from irradiated endothelial cells. Clin Cancer Res 13 (2007) 851-857
52. Cheng J.C., Liu H.S., Wu J.K., et al. Inclusion of biological factors in parallel-architecture normal-tissue complication probability model for radiation-induced liver disease. Int J Radiat Oncol Biol Phys 62 (2005) 1150-1156